𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis

✍ Scribed by Kumar, Pawan; Benedict, Ryan; Urzua, Fernando; Fischbach, Claudia; Mooney, David; Polverini, Peter


Book ID
109885901
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
783 KB
Volume
85
Category
Article
ISSN
0023-6837

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Combination of human plasminogen kringle
✍ Guang-Hui Jin; Ding-Yuan Ma; Ning Wu; Faiz M.M.T Marikar; Shun-Zi Jin; Wei-Wei J πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 660 KB

## Abstract Antiangiogenic therapy could destroy tumor vasculature and inhibit tumor growth. It might inhibit tumor growth significantly when used as a single treatment modality and its therapeutic benefit may even be greater when used in combination with established treatment modalities such as ra

Therapy-induced antitumor vaccination in
✍ Enrica Balza; Barbara Carnemolla; Lorenzo Mortara; Patrizia Castellani; Debora S πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 768 KB

## Abstract L19‐IL2 and L19TNFΞ± are fusion proteins composed of L19(scFv), specific for the angiogenesis‐associated ED‐B containing fibronectin isoform and IL‐2 or TNFΞ±. Because of the tumor targeting properties of L19, IL‐2 and TNFΞ± concentrate at therapeutic doses at the tumor vascular level. To